Rabeprazole Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01129 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Smouldering systemic mastocytosis | KG + DL |
| 2 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 3 | active peptic ulcer disease | KG + DL |
| 4 | duodenogastric reflux | KG + DL |
| 5 | gastroduodenitis | KG + DL |
| 6 | duodenal obstruction | KG + DL |
| 7 | peptic ulcer perforation | KG + DL |
| 8 | gastrojejunal ulcer | KG + DL |
| 9 | gastric ulcer (disease) | KG + DL |
| 10 | abnormality of glucagon secretion | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.